Search Result "TCR- chain"
The TCR/CD3 Complex: Opening the Gate to Successful Vaccination
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3290-3300
Author(s): Pilar Portoles, Jose M. Rojo
Major Highlights of the CAR-TCR Summit, Boston, 2016
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 10 Year: 2017 Page: 1344-1350
Author(s): Vita Golubovskaya,Robert Berahovich,Shirley Xu,Hizkia Harto,Lijun Wu
TCR Peptide Vaccination in Multiple Sclerosis: Boosting a Deficient Natural Regulatory Network that may Involve TCR-Specific CD4+CD25+ Treg Cells
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 217-229
Author(s): Arthur A. Vandenbark
Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 185-193
Author(s): Gregory G. Burrows
T-Cell Antigen Receptor Assembly and Cell Surface Expression Is Not Affected by Treatment with T-Cell Antigen Receptor-Alpha Chain Transmembrane Peptide
Journal: Protein & Peptide Letters
Volume: 14 Issue: 3 Year: 2007 Page: 299-303
Author(s): Nozomu Kurosaka, Andrea Bolte, Marina Ali, Nicholas Manolios
Modulation of T Cell Immunity by TCR / pMHC Dwell Time and Activating / Inhibitory Receptor Pairs on the Antigen-Presenting Cell
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 3 Year: 2003 Page: 233-244
Author(s): Alexis M. Kalergis
Recognition of Classical and Heavy Chain Forms of HLA-B27 by Leukocyte Receptors
Journal: Current Molecular Medicine
Volume: 4 Issue: 1 Year: 2004 Page: 59-65
Author(s): Rachel L. Allen, John Trowsdale
Negative Regulation of TCR Signaling in Immunological Tolerance: Taming Good and Evil
Journal: Current Immunology Reviews
Volume: 4 Issue: 4 Year: 2008 Page: 190-198
Author(s): Martina Gatzka, Craig M. Walsh
Glycolipid Stimulators for NKT Cells Bearing Invariant Vα19-Jα33 TCR α Chains
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8 Issue: 3 Year: 2008 Page: 285-289
Author(s): M. Shimamura
MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 344-352
Author(s): Arvind Chhabra